Featured news item
Sebastian is recognized for his leadership in Freshfields’ representation of AstraZeneca in its $39 billion purchase of Alexion Pharmaceuticals - the largest acquisition of a US company, acquisition financing and pharmaceutical deal of 2020.
Freshfields serves as issuer’s counsel to Zymergen on its IPO on Nasdaq as a public benefit corporation valued in excess of $4bn
Freshfields served as issuer’s counsel to Zymergen Inc. on its IPO as a public benefit corporation on the Nasdaq Global Select Market. The IPO values the company in excess of $4 billion. The company ...
A team from Freshfields has advised Oracle Corporation on its SEC-registered debt offering of $15 billion aggregate principal amount of senior debt securities, consisting of $2.75 billion aggregate ...